Three goal-directed hemodynamic strategies for fluid management during major abdominal cancer surgery
Official title: Surgical Management and Advanced Real Time Technologies for Fluid Optimization in Major Abdominal Surgery: A Randomized Controlled Trial
Run by ASST Sette Laghi · NCT06871150 · Data updated 2026-11-12
This trial tests whether three goal-directed fluid-management approaches (FLOTRAC, the Hypotension Prediction Index, and HPI combined with Assisted Fluid Management) help people aged 65 and older having major abdominal cancer surgery keep blood pressure stable and reduce complications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | ASST Sette Laghi Academic / other |
| Locations | 3 sites (Bergamo, Italy and 2 other locations) |
| Status | Recruiting |
| Started | March 2, 2026 |
| Main results expected | September 30, 2026 |
| Study ends | October 30, 2026 |
| Registry record updated | March 25, 2026 |
| Trial ID | NCT06871150 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 65 or older with ASA II–IV and a revised cardiac index ≥2 who are scheduled for elective major abdominal oncologic surgery with planned invasive arterial monitoring and an expected operative time >120 minutes.
✕Probably not a fit
Patients undergoing emergency surgery, those with severe chronic renal failure (creatinine clearance <30 ml/min), NYHA class IV heart failure, liver surgery, pregnancy, or contraindications to pulse-contour monitoring are excluded and unlikely to benefit from these interventions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter, randomized trial in tertiary hospitals comparing three intraoperative hemodynamic strategies for older patients undergoing elective major abdominal oncologic surgery. Patients are randomized to management guided by FLOTRAC, HPI, or HPI plus Assisted Fluid Management (AFM) software, with clinicians retaining final treatment decisions. Continuous arterial waveform monitoring and protocolized fluid/vasopressor guidance aligned with goal-directed hemodynamic therapy will be applied during procedures expected to last over two hours. Outcomes include intraoperative hemodynamic stability and postoperative complications such as acute kidney injury, myocardial ischemia, and infections.
Why it matters
Potential benefit: If successful, these approaches could reduce intraoperative hypotension and lower rates of postoperative complications like acute kidney injury, myocardial ischemia, and sepsis.
How similar studies have gone: Previous trials of algorithm-driven and goal-directed intraoperative fluid management, including hypotension prediction tools, have shown reductions in intraoperative hypotension and some postoperative complications, but direct evidence for combining HPI with AFM is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 65 years. * ASA physical status II-III-IV. * Patients undergoing elective major abdominal oncological surgery. * Revised Cardiac Index Score ≥ 2. * Plan to perform the procedure with invasive arterial monitoring. * Expected surgical time greater than 120 minutes. Exclusion Criteria: * Emergency or urgent surgeries. * Severe chronic renal failure (creatinine clearance \< 30 ml/min). * Chronic heart failure (NYHA Class IV). * Pregnant women. * Contraindications to pulse contour hemodynamic monitoring. * Liver surgery. * Patient refusal.
Where it's running
-
ASST Papa Giovanni XXIII
Bergamo, Italy, Italy Recruiting -
Humanitas Research Hospital
Rozzano, Italy, Italy Recruiting -
University Hospital Varese ASST SetteLaghi
Varese, Italy, Italy Recruiting
Study contacts
- Study coordinator: Luca Guzzetti Luca Guzzetti, MD
- Email: luca.guzzetti@asst-settelaghi.it
- Phone: 0039 0332393447
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hemodynamic Changes and Trigeminocardiac Reflex During Bimaxillary Orthognathic Surgery
This study tests how blood pressure, heart rate, and oxygen levels change during bimaxillary orthognathic surgery and whether the trigeminocardiac reflex occurs.
-
Sedation with dexmedetomidine, propofol, or both during cataract surgery
This project will test whether dexmedetomidine, propofol, or their combination (each given with fentanyl) provides the best sedation, safety, and surgeon satisfaction for adults having cataract surgery.
-
MRI-derived Pressure Ratio (MPR) to predict stroke risk in intracranial atherosclerosis (ICAS)
This study will test whether a new MRI-derived pressure ratio (MPR) can help predict 1-year stroke risk in adults (18–80) with 50–99% intracranial atherosclerotic stenosis in the anterior circulation.
-
Using a suprasternal ultrasound to see if heart filling changes help guide fluids in kids undergoing surgery
This observational study tests whether measuring aortic flow with a suprasternal Doppler can predict which pediatric patients will benefit from fluid adjustments during surgery.
-
Using a prediction algorithm to prevent low blood pressure during abdominal aortic aneurysm repair
This trial will try whether using the Hemosphere platform's hypotension prediction index to guide hemodynamic therapy can reduce low blood pressure during abdominal aortic aneurysm repair.
-
Investigating fluid responsiveness and venous congestion in critically ill patients during volume expansion
This study is testing how well critically ill patients respond to extra fluids and if they have too much fluid in their veins during treatment in the ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.